Home  >  Research  >  Labs  >  Cancer Program  >  TARGETED DRUG DELIVERY, IMAGING AND THERAPY


We focus on developing strategies to specifically target diseases such as cancer and atherosclerosis for diagnostic imaging and local therapeutic interventions.

  • Cancer and cardiovascular disease
  • Fibro-inflammatory cells and extracellular matrix
  • Tissue homing peptides and targeted delivery
  • In vivo imaging
  • Targeted therapy
  • Nanotechnology

Our goal is to identify diagnostic and therapeutic overlaps between different types of chronic fibro-inflammatory diseases such as cancer, atherosclerotic disease and other tissue fibrosis.

Associate Professor Juliana Hamzah

Associate Professor Juliana Hamzah

Targeted Drug Delivery, Imaging and Therapy (Theme Head - Therapeutic Targeting)

Read more


Perkins researcher elected as prestigious new Fellow

Professor Alistair Forrest from the Harry Perkins Institute of Medical Research has been selected alongside 27 new Fellows of the Australian Academy of Health and Medical Sciences. Professor Forrest is internationally regarded for his pioneering work, which has been driving forward our understanding of human diseases and the complex behaviour…

Read More

Molecular machines stop cancer’s clock

Head of the laboratory for Synthetic Biology and Drug Discovery, Professor Oliver Rackham, says cancer cells grow uncontrollably whereas normal cells limit their growth. “A normal cell grows for just the right amount of time that is required for us to develop and maintain our bodies. “They control their growth with…

Read More

Stem cell reprogramming mystery clarified by new findings

In a study, published in Cell Stem Cell, researchers from the University of Western Australia, the Harry Perkins Institute of Medical Research, and Monash University describe key drivers of the process by which cells from mature tissues of the body, such as skin, can be deliberately converted into stem cells that…

Read More